Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene

Neuroscience Letters

Volumn 220, Issue 1, 1996, Pages 53-56

  Boado, Ruben J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cerebrolysin; gene regulation; glucose transporter; luciferase; polymerase chain reaction; protein kinase

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CEREBROLYSIN; GLUCOSE TRANSPORTER; LUCIFERASE; MESSENGER RNA; PHORBOL ESTER; PROTEIN KINASE INHIBITOR; STAUROSPORINE;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; AMINO ACIDS; BASE SEQUENCE; BLOOD-BRAIN BARRIER; BRAIN; ENDOTHELIUM; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GENES, REPORTER; GLUCOSE TRANSPORTER TYPE 1; LUCIFERASES; MOLECULAR SEQUENCE DATA; MONOSACCHARIDE TRANSPORT PROTEINS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; STAUROSPORINE;

EID: 0030573035     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13237-7     Document Type: Article

References (20)

1. [1] Akai, F., Himura, S., Sato, T., Iwamoto, N., Fujimoto, M., Ioku, M. and Hashimoto, S., Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transactions of fimbria-fornix in the rat, Histol. Histopathol., 7 (1992) 213-221.
2. [2] Arthur, F.E., Shivers, R.R. and Bowman, P.D., Astrocyte-mediated induction of tight junctions in brain capillary endothelium: an efficient in vitro model, Dev, Brain Res., 36 (1987) 155-159.
3. [3] Boado, R.J., Brain-derived peptides regulate the steady state levels and increase stability of the blood-brain barrier GLUT1 glucose transporter mRNA, Neurosci. Lett., 197 (1995) 179-182.
4. [4] Boado, R.J. and Pardridge, W.M., Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5′-untranslated region, Mol. Cell. Neurosci., 1 (1990) 224-232.
5. [5] Boado, R.J. and Pardridge, W.M., Glucose deprivation causes post-transcriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization, J. Neurochem., 60 (1993) 2290-2296.
6. [6] Boado, R.J. and Pardridge, W.M., Measurement of blood-brain barrier GLUT1 glucose transporter and actin mRNA by a quantitative polymerase chain reaction assay, J. Neurochem., 62 (1994) 2085-2090.
7. [7] Boado, R.J., Black, K.L. and Pardridge, W.M., Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors, Mol. Brain Res., 27 (1994) 51-57.
8. [8] Boado, R.J., Tsukamoto, H. and Pardridge, W.M., Evidence for transcriptional control elements in 5′-untranslated region of GLUT1 glucose transporter mRNA, J. Neurochem., 67 (1996) 1335-1343.
9. [9] Boado, R.J., Wang, L. and Pardridge, W.M., Enhanced expression of the blood-brain barrier GLUT1 glucose transporter gene by brain-derived factors, Mol. Brain Res., 22 (1994) 259-267.
10. [10] Flier, J.S., Mueckler, M., McCall, A.L. and Lodish, H.F., Distribution of glucose transporter messenger RNA transcripts in tissues of rat and man, J. Clin. Invest., 79 (1987) 657-661.
11. [11] Janzer, R.C. and Raff, M.C., Astrocytes induce blood-brain barrier properties in endothelial cells, Nature, 325 (1987) 253-257.
12. [12] Pardridge, W.M. and Boado, R.J., Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter. In The Blood-Brain Barrier: Cellular and Molecular Biology, Raven Press, New York, 1993, pp. 395-440.
13. [13] Ruther, E., Ritter, R., Apecechea, M., Freytag, S. and Windisch, M., Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT), Pharmacopsychiatry, 27 (1994) 32-40.
14. [14] Sandouk, T., Reda, D. and Hofmann, C., The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability, Endocrinology, 133 (1993) 352-359.
15. [15] Stewart, P.A. and Wiley, M.J., Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimera, Dev. Biol., 84 (1981) 183-192.
16. [16] Takakura, Y., Kuentzel, S.L., Raub, T.J., Davies, A., Baldwin, S.A. and Borchardt, R.T., Hexose uptake in primary cultures of bovine brain microvessel endothelial cells. 1. Basic characteristics and effects of glucose and insulin, Biochim. Biophys. Acta, 1070 (1991) 1-10.
17. [17] Takata, K., Kasahara, T., Kasahara, M., Ezaki, O. and Hirano, H., Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers, Biochem. Biophys. Res. Commun., 173 (1990) 67-73.
18. [18] Tsukamoto, H., Boado, R.J. and Pardridge, W.M., Differential expression in glioblastoma multiforme and cerebral hemangioblastoma of cytoplasmic proteins that bind two different domains within the 3′-untranslated region of the human glucose transporter 1 messenger RNA, J. Clin. Invest., 97 (1996) 2823-2832.
19. [19] Van Steeg, H., Van Oostrom, C.T.M., Hodemaekers, H.M., Peters, L. and Thomas, A.A.M., The translation in vitro of rat ornithine decarboxylase mRNA is blocked by its 5′ untranslated region in a polyamine-independent way, Biochem. J., 274 (1991) 521-526.
20. [20] Xiong, H., Wojtowicz, J.M. and Baskys, A., Brain tissue hydrolysate acts on presynaptic adenosine receptors in the rat hippocampus, Can. J. Physiol. Pharmacol., 73 (1995) 1194-1197.